Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study-Reference-Cited by-同舟云学术

Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study

Published:2016-11 Issue: Volume:101 Page:1-8
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Nosaki Kaname,Satouchi Miyako,Kurata Takayasu,Yoshida Tatsuya,Okamoto Isamu,Katakami Nobuyuki,Imamura Fumio,Tanaka Kaoru,Yamane Yuki,Yamamoto Nobuyuki,Kato Terufumi,Kiura Katsuyuki,Saka Hideo,Yoshioka Hiroshige,Watanabe Kana,Mizuno Keiko,Seto Takashi

Funder

AstraZeneca K.K

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

2. Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR;Maemondo;N. Engl. J. Med.,2010

3. for the West Japan Oncology group, Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label randomised phase 3 trial;Mitsudomi;Lancet Oncol.,2010

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N. Engl. J. Med.,2009

5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol.,2012

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeat biopsy versus initial biopsy in terms of complication risk factors and clinical outcomes for patients with non-small cell lung cancer: a comparative study of 113 CT-guided needle biopsy of lung lesions;Frontiers in Oncology;2024-05-13

2. A Radiomics-clinical Nomogram based on CT Radiomics to Predict Acquired T790M Mutation Status in Non-small Cell Lung Cancer Patients;Current Medical Imaging Reviews;2024-04-22

3. Comprehensive molecular and clinical insights into non-small cell lung cancer transformation to small cell lung cancer with an illustrative case report;Journal of Drug Targeting;2024-03-25

4. Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study;BMC Pulmonary Medicine;2023-12-01

5. Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC;Scientific Reports;2023-11-21